A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of SXRN Injection in Patients With Cancer Cachexia

Clinical trial NCT07231120 · RECRUITING

Trial details

NCT number: NCT07231120
Sponsor: Jiangsu Nutai Biologics Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cachexia-Anorexia Syndrome Solid Tumor Malignancies

Start date: 2025-11-17
Primary completion: 2026-11-09
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.